Results 191 to 200 of about 5,260,545 (402)

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Electrosprayed Chitosan Nanoparticles for Drug Carriers in Cancer Treatment - A Mini Review

, 2023
Fatoni Udaneni, Muchfi Azizah, Dewanto Harjunowibowo, Mohammad Alauhdin, Peni Indrayudha, Yulianto Agung Rezeki   +5 more
openalex   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Synthesis And Characterization Of Fe0@Chitosan/Cellulose Green Nanocomposite As Advanced Carrier For Ibuprofen Drug; Loading And Release Properties [PDF]

, 2022
Mostafa R. Abukhadra, Fatma A. El Kashief, Jong Seong Khim, Jamaan S. Ajarem, Ahmed A. Allam, Gasem Mohammad Abu-Taweel   +5 more
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Formulation of Metal–Organic Framework-Based Drug Carriers by Controlled Coordination of Methoxy PEG Phosphate: Boosting Colloidal Stability and Redispersibility

, 2021
Xu Chen, Yunhui Zhuang, Nakul Rampal, Rachel E. Hewitt, Giorgio Divitini, Christopher A. O’Keefe, Xiewen Liu, Daniel J. Whitaker, John W. Wills, Ravin Jugdaohsingh, Jonathan J. Powell, Han Yu, Clare P. Grey, Oren A. Scherman, David Fairen‐Jiménez   +14 more
openalex   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Using a Natural Clay Mineral as an Active Drug Carrier to Promote Hair Growth. [PDF]

Pharmaceuticals (Basel)
Liu Z, Huang W, Xu S, Nan M, Cui X, Wang Y, Jin Z, Meng W, Meng J, Pi L.   +9 more
europepmc   +1 more source

Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system [PDF]

, 2018
Achilefu, Samuel, Gu, Yueqiing, Li, Siwen, Liu, Yuxi, Rui, Yalan, Tang, Liping   +5 more
core   +2 more sources

Thiolated and Carboxymethylated Jackfruit Seed Starch Nanocrystals as Polymeric Drug Carriers for Curcumin Delivery to Cancer Cells [PDF]

Olalekan Adeyinka Balogun‐Agbaje, Michael Ayodele Odeniyi   +1 more
openalex   +1 more source